The COVID 19 pandemic highlighted the critical importance of a resilient biopharmaceutical ecosystem capable of responding rapidly to health crises.
Morphocell Technologies, a biotechnology company developing next-generation tissue therapies for…
BIOQuébec welcomes the renewal of the Quebec Life Sciences Strategy for 2025-2028, which reaffirms…
The life sciences sector is attracting increasing amounts of venture capital due to its potential for innovation and…
The integration of new medical technology into Quebec’s hospital network is based above all on a rigorous administrative process, supervised…
AbbVie (NYSE: ABBV), jointly with the adMare BioInnovations, announced the launch of the AbbVie Biotech Innovators Award, a prize to…
Québec is home to a thriving biotechnology services ecosystem made up of…
We use cookies to improve your browsing experience and analyze our traffic. By clicking "Accept", you consent to our use of cookies.
Privacy Policy